블루엠텍

439580KOSDAQ기타 전문 도매업

39.8 / 100

Reference Date: 2026-06-10

Financial Score7.0 / 40

News Sentiment18.8 / 25

Momentum2.0 / 20

Disclosure12.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 27.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BlueEmtek operates pharmaceutical distribution platforms such as BluePharmKorea and KoolPharm, selling specialized medications to hospitals and pharmacies. The company also provides the online order management system 'BOS' and cold chain logistics solutions to enhance pharmaceutical distribution efficiency, and operates a medical staffing platform called BlueDoc.

Number of Employees

98people

Average Salary

48.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 13.364.0Point

PBR

1.66Industry Average 0.580.0Point

2.9x industry avg (risky)

ROE

-9.81Industry Average 2.090.0Point

Well below industry avg

Debt Ratio

20.30Industry Average 7.870.0Point

2.6x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲28.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼270.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.1% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75

Positive
블루엠텍, 10억 규모 자사주 취득 신탁계약
블루엠텍이 자사주 취득 신탁계약을 통해 주가 저평가를 해소하고 주주 가치를 증대시키려는 전략을 발표했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 2,200Won52-week high 6,42052-week low 2,200

1-month return0.0Point

1m -27.03% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 1Neutral 3Negative 0

Positive주요사항보고서(자기주식취득신탁계약체결결정)2026-06-04
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-29
Neutral주식등의대량보유상황보고서(일반)2026-05-29
Neutral분기보고서 (2026.03)2026-05-15